67th Combat Support Hospital (United States)

Visory Health Names Highly Decorated Army Colonel to Serve as Chief Clinical Officer

Retrieved on: 
목요일, 11월 9, 2023

Visory Health , a simple, patient-first platform that provides lower prices on prescriptions, announces the appointment of highly decorated Army Colonel Dr. Cheryl Creamer as the company’s Chief Clinical Officer.

Key Points: 
  • Visory Health , a simple, patient-first platform that provides lower prices on prescriptions, announces the appointment of highly decorated Army Colonel Dr. Cheryl Creamer as the company’s Chief Clinical Officer.
  • Veterans often face significant challenges when it comes to accessing healthcare, particularly in terms of mental health support and prescription medications.
  • According to RAND research , only about half of all veterans who need mental health care ever receive it due to a series of roadblocks.
  • Dr. Creamer brings unmatched expertise, leadership and compassion to Visory Health, positioned as a liaison between Veterans and affordable medications.

Maxwell Biosciences Appoints Major General (Ret.) Barb Holcomb, RN, BSN, MSN to Its Board of Directors

Retrieved on: 
수요일, 10월 18, 2023

Austin, Texas--(Newsfile Corp. - October 18, 2023) - Maxwell Biosciences ("Maxwell"), a preclinical drug platform company developing a synthetic immune system that may serve as a key biodefense asset, today announced the appointment of Major General (Retired) Barb Holcomb, RN, BSN, MSN to its Board of Directors.

Key Points: 
  • Austin, Texas--(Newsfile Corp. - October 18, 2023) - Maxwell Biosciences ("Maxwell"), a preclinical drug platform company developing a synthetic immune system that may serve as a key biodefense asset, today announced the appointment of Major General (Retired) Barb Holcomb, RN, BSN, MSN to its Board of Directors.
  • This appointment adds one of the world's top national security and biodefense research and logistics executives to Maxwell's board.
  • "I am pleased to welcome General Holcomb's leadership in national security and patient care to Maxwell's board as we approach human trials next year," said Maxwell Biosciences Chairman and CEO Joshua McClure.
  • "General Holcomb is a highly patient-focused medical professional with decades of deep respect within the global and national security biodefense communities.